Treating severe frostbite with iloprost at high altitude
Treatments studied
Part of Injuries & trauma clinical trials.
This trial tests whether a medicine called iloprost, given through an IV line, can help treat severe frostbite at high altitudes. It may help save damaged tissue and improve recovery for people with severe frostbite.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have severe frostbite (grade 3 or 4).
- The frostbitten area must have started thawing less than 72 hours ago.
- You must be 18 years or older.
- You must be able to give written consent to participate.
- You cannot be pregnant, and you must not have any medical conditions that make the treatment unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a drug called epoprostenol, given with standard care, to see if it helps people with severe frostbite by improving blood flow and reducing tissue damage. It may help save fingers and toes from needing amputation.
This trial tests a new way to help people who have both severe COPD and a type of high blood pressure in the lungs. The study uses an inhaled medication called iloprost to see if it can improve blood flow and reduce symptoms.
This study tests a medicine called prostacyclin (given through a vein) to see if it helps people on a breathing machine with a lung infection. The goal is to reduce inflammation and improve recovery.
This trial tests a medicine called iloprost, given through an IV, to see if it can help relieve the pain of a sickle cell crisis. If you are hospitalized for a crisis, this treatment may speed up your recovery and reduce pain.
This study tests whether giving iron through a vein helps you perform better at high altitude. It may help you if you are a healthy adult who exercises regularly.
This study tests an inhaled powder medication called TPIP (treprostinil palmitil inhalation powder) to see if it can improve symptoms and exercise ability in people who have both interstitial lung disease and pulmonary hypertension. The study will compare TPIP against a placebo (a dummy treatment without the active drug) to understand how well it works and if it is safe.
Hear when a new Frostbite trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.